SI Stock Forecast: Shoulder Innovations, Inc. Price Predictions for 2026-2027
The 4 Wall Street analysts covering Shoulder Innovations, Inc. hold a median 12-month price target of $28 — +36.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 63 of 100 as at 21 Nov 2026 — in the upper half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Shoulder Innovations, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (90): Analysts have, on balance, been raising their forecasts.
Accruals (33): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
SI stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on SI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +36.5% from it.
Of the 20 most recent actions, 5 moved their price target up and 4 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 12 Oct 2026 | BTIG | Maintains | Buy | $26 → $27 |
| 10 Aug 2026 | UBS | Maintains | Buy | $27 → $28 |
| 7 Aug 2026 | BTIG | Maintains | Buy | $24 → $26 |
| 7 Aug 2026 | Piper Sandler | Reiterates | Overweight | $19 → $25 |
| 28 July 2026 | UBS | Initiates | Buy | $27 |
| 8 May 2026 | Piper Sandler | Reiterates | Overweight | $18 → $19 |
| 11 Mar 2026 | BTIG | Maintains | Buy | — |
| 2 Dec 2025 | Morgan Stanley | Maintains | Overweight | — |
| 12 Nov 2025 | Piper Sandler | Reiterates | Overweight | — |
| 9 Sept 2025 | BTIG | Reiterates | Buy | — |
| 26 Aug 2025 | Morgan Stanley | Initiates | Overweight | — |
| 25 Aug 2025 | Goldman Sachs | Initiates | Buy | — |
| 25 Aug 2025 | Jefferies | Initiates | Buy | — |
| 25 Aug 2025 | Piper Sandler | Initiates | Overweight | — |
| 6 Mar 2023 | Wedbush | Downgrade | Underperform | $4.00 |
| 2 Mar 2023 | Canaccord Genuity | Downgrade | Hold | $25 → $9.00 |
| 2 Mar 2023 | JP Morgan | Downgrade | Underweight | — |
| 1 Mar 2023 | Keefe, Bruyette & Woods | Downgrade | Market Perform | $25 → $16 |
| 9 Jan 2023 | Goldman Sachs | Maintains | Neutral | $35 → $10 |
| 9 Jan 2023 | Morgan Stanley | Maintains | Underweight | $24 → $13 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for SI.
This page is one stock. Monday covers all of them.
SI appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
SI vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Shoulder Innovations, Inc. returned +45.6% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
SI analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 8.9×
- Price / book
- 3.3×
- EV / EBITDA
- —
Cheaper than 13% of US stocks
Cheaper than 28% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 78.3%
- Operating margin
- −85.1%
- Net margin
- —
Higher than 90% of US stocks
Higher than 15% of US stocks
- Return on equity
- −28.7%
- Return on assets
- −23.8%
- Dividend yield
- —
Higher than 28% of US stocks
Higher than 17% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Shoulder Innovations, Inc. has a market value of $418.9M and an enterprise value of $407.0M.
Revenue in the twelve months to 30 June 2026: $60.1M. The latest quarter grew 56.0% year on year.
Net income over the same four quarters: −$35.0M, a −58.3% net margin.
Diluted earnings per share, trailing twelve months: −$1.92.
Free cash flow in the twelve months to 30 June 2026: −$47.1M.
Shoulder Innovations, Inc. employs 56 people — $1.1M of revenue per employee.
Data provided by Twelve Data
SI and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at SI’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Shoulder Innovations, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about SI
What is the SI stock price forecast for 2026-2027?
The 4 Wall Street analysts covering Shoulder Innovations, Inc. have a median 12-month price target of $28, with estimates ranging from $25 to $28. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is SI stock a buy right now?
Of the 4 analysts covering Shoulder Innovations, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Shoulder Innovations, Inc. 63 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank SI?
As at 21 Nov 2026, Shoulder Innovations, Inc. ranks 63 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Revisions (90 of 100).
Will SI stock go up?
No one can know that. What the data says: the median 12-month target from 4 analysts implies +36.5% from the last close, and Ticker Nerd's factor model ranks Shoulder Innovations, Inc. 63 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the SI stock forecast for 2030?
No analyst covering Shoulder Innovations, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $25 to $28 over the next 12 months.
How has SI stock performed over the past year?
Shoulder Innovations, Inc. returned +45.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Shoulder Innovations, Inc. do?
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on shoulder arthroplasty solutions. Shoulder Innovations designs, develops, manufactures, and distributes implant systems and related surgical tools used in shoulder replacement procedures.
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on shoulder arthroplasty solutions. Shoulder Innovations designs, develops, manufactures, and distributes implant systems and related surgical tools used in shoulder replacement procedures. Its product portfolio includes advanced total and reverse shoulder arthroplasty systems, tray components, planning software, and enabling instruments that support preoperative planning, implant placement, and procedural efficiency. The company’s InSet Glenoid technology is central to its platform, supporting fixation and stability in shoulder implants while addressing clinical challenges in shoulder reconstruction. Shoulder Innovations serves hospitals, ambulatory surgery centers, surgeons, and orthopedic care teams that rely on specialized devices for shoulder surgery. Headquartered in Grand Rapids, Michigan, Shoulder Innovations focuses exclusively on the shoulder surgical care market, making it a specialized participant in the broader orthopedic medical device industry.
CEO Mr. Robert Ball · 56 employees · United States · https://www.shoulderinnovations.com